Introduction
The term agnogenic myeloid metaplasia of the spleen was first used by Jackson, Barker & Lemon (1940) , in describing a condition in which the spleen becomes the site of extramedullary haematopoiesis. This extramedullary haematopoiesis, which involves the whole reticulo-endothelial system, is maximal in the spleen and results clinically in varying degrees of hepatomegaly and gross splenomegaly, and had been considered compensatory to failure of the bone marrow to carry out its haematopoietic function.
Bone marrow changes in these patients will vary from hyperplastic to hypoplastic with (Fishman & Ballinger, 1965) . In considering the criteria for splenectomy in patients with myelofibrosis and agnogenic myeloid metaplasia, specific indications would include:
(1) Clear-cut evidence of splenic red blood cell destruction associated with decreased red blood cell survival time.
(2) Absence 
